Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 199

1.

Renal toxicity of adjuvant chemoradiotherapy with cisplatin in gastric cancer.

Welz S, Hehr T, Kollmannsberger C, Bokemeyer C, Belka C, Budach W.

Int J Radiat Oncol Biol Phys. 2007 Dec 1;69(5):1429-35. Epub 2007 Aug 9.

PMID:
17692474
2.

Four consecutive multicenter phase II trials of adjuvant chemoradiation in patients with completely resected high-risk gastric cancer: the experience of the German AIO/ARO/CAO group.

Oechsle K, Bokemeyer C, Hartmann JT, Budach W, Trarbach T, Stahl M, Boehlke I, Kollmannsberger C; German AIO/ARO/CAO group.

J Cancer Res Clin Oncol. 2009 Feb;135(2):163-72. doi: 10.1007/s00432-008-0463-6. Epub 2008 Sep 30.

PMID:
18825411
4.

Adjuvant intraperitoneal chemotherapy with cisplatinum, mitoxantrone, 5-fluorouracil, and calcium folinate in patients with gastric cancer: a phase II study.

Topuz E, Basaran M, Saip P, Aydiner A, Argon A, Sakar B, Tas F, Uygun K, Bugra D, Aykan NF.

Am J Clin Oncol. 2002 Dec;25(6):619-24.

PMID:
12478012
5.

Phase II trial of weekly paclitaxel, cisplatin plus infusional high dose 5-fluorouracil and leucovorin for metastatic urothelial carcinoma.

Lin CC, Hsu CH, Huang CY, Cheng AL, Vogelzang NJ, Pu YS.

J Urol. 2007 Jan;177(1):84-9; discussion 89.

PMID:
17162009
6.

Adjuvant treatment of high-risk, radically resected gastric cancer patients with 5-fluorouracil, leucovorin, cisplatin, and epidoxorubicin in a randomized controlled trial.

Cascinu S, Labianca R, Barone C, Santoro A, Carnaghi C, Cassano A, Beretta GD, Catalano V, Bertetto O, Barni S, Frontini L, Aitini E, Rota S, Torri V, Floriani I; Italian Group for the Study of Digestive Tract Cancer, Pozzo C, Rimassa L, Mosconi S, Giordani P, Ardizzoia A, Foa P, Rabbi C, Chiara S, Gasparini G, Nardi M, Mansutti M, Arnoldi E, Piazza E, Cortesi E, Pucci F, Silva RR, Sobrero A, Ravaioli A.

J Natl Cancer Inst. 2007 Apr 18;99(8):601-7.

PMID:
17440161
7.

Concurrent liposomal cisplatin (Lipoplatin), 5-fluorouracil and radiotherapy for the treatment of locally advanced gastric cancer: a phase I/II study.

Koukourakis MI, Giatromanolaki A, Pitiakoudis M, Kouklakis G, Tsoutsou P, Abatzoglou I, Panteliadou M, Sismanidou K, Sivridis E, Boulikas T.

Int J Radiat Oncol Biol Phys. 2010 Sep 1;78(1):150-5. doi: 10.1016/j.ijrobp.2009.07.1733.

PMID:
20138443
8.

Adjuvant chemoradiotherapy for gastric carcinoma: dosimetric implications of conventional gastric bed irradiation and toxicity.

Pemberton L, Coote J, Perry L, Khoo VS, Saunders MP.

Clin Oncol (R Coll Radiol). 2006 Nov;18(9):663-8.

PMID:
17100151
9.

Concurrent chemoradiotherapy followed by adjuvant chemotherapy in Asian patients with nasopharyngeal carcinoma: toxicities and preliminary results.

Tan EH, Chua ET, Wee J, Tan T, Fong KW, Ang PT, Lee KS, Lee KM, Khoo-Tan HS, Leong SS, Ong YK, Foo KF, Sethi VK, Chua EJ.

Int J Radiat Oncol Biol Phys. 1999 Oct 1;45(3):597-601.

PMID:
10524411
10.

Phase II study of preoperative paclitaxel/cisplatin with radiotherapy in locally advanced esophageal cancer.

Kim DW, Blanke CD, Wu H, Shyr Y, Berlin J, Beauchamp RD, Chakravarthy B.

Int J Radiat Oncol Biol Phys. 2007 Feb 1;67(2):397-404. Epub 2006 Nov 9.

PMID:
17097833
11.

The management of gastric adenocarcinoma with postoperative chemoirradiation. A non-randomized comparison of oral UFT and 5-FU.

Surenkok S, Beyzadeoglu M, Oysul K, Ozyigit G, Ataergin S, Arpaci F, Ozet A.

Tumori. 2008 Jan-Feb;94(1):70-4.

12.

Adjuvant chemoradiation using 5-fluorouracil/folinic acid/cisplatin with or without paclitaxel and radiation in patients with completely resected high-risk gastric cancer: two cooperative phase II studies of the AIO/ARO/ACO.

Kollmannsberger C, Budach W, Stahl M, Schleucher N, Hehr T, Wilke H, Schleicher J, Vanhoefer U, Jehle EC, Oechsle K, Trarbach T, Boehlke I, Kanz L, Hartmann JT, Bokemeyer C.

Ann Oncol. 2005 Aug;16(8):1326-33. Epub 2005 May 26.

PMID:
15919686
13.

Conformal radiotherapy in the adjuvant treatment of gastric cancer: Review of 82 cases.

Kassam Z, Lockwood G, O'brien C, Brierley J, Swallow C, Oza A, Siu L, Knox JJ, Wong R, Cummings B, Kim J, Moore M, Ringash J.

Int J Radiat Oncol Biol Phys. 2006 Jul 1;65(3):713-9. Epub 2006 Apr 19.

PMID:
16626887
14.

Concurrent chemoradiotherapy in adjuvant treatment of breast cancer.

Ismaili N, Mellas N, Masbah O, Elmajjaoui S, Arifi S, Bekkouch I, Ahid S, Bazid Z, Tazi MA, Erraki A, El Mesbahi O, Benjaafar N, El Gueddari Bel K, Ismaili M, Afqir S, Errihani H.

Radiat Oncol. 2009 Apr 7;4:12. doi: 10.1186/1748-717X-4-12.

15.

Phase II trial of preoperative chemoradiation in patients with localized gastric adenocarcinoma (RTOG 9904): quality of combined modality therapy and pathologic response.

Ajani JA, Winter K, Okawara GS, Donohue JH, Pisters PW, Crane CH, Greskovich JF, Anne PR, Bradley JD, Willett C, Rich TA.

J Clin Oncol. 2006 Aug 20;24(24):3953-8.

PMID:
16921048
16.

Combined adjuvant radiochemotherapy with IMRT/XELOX improves outcome with low renal toxicity in gastric cancer.

Boda-Heggemann J, Hofheinz RD, Weiss C, Mennemeyer P, Mai SK, Hermes P, Wertz H, Post S, Massner B, Hieber U, Hochhaus A, Wenz F, Lohr F.

Int J Radiat Oncol Biol Phys. 2009 Nov 15;75(4):1187-95. doi: 10.1016/j.ijrobp.2008.12.036. Epub 2009 May 4.

PMID:
19409725
17.

Adjuvant chemo-radiotherapy in patients with gastric cancer.

Capizzello A, Tsekeris PG, Pakos EE, Papathanasopoulou V, Pitouli EJ.

Indian J Cancer. 2006 Oct-Dec;43(4):174-9.

18.
19.

Postoperative chemotherapy followed by conformal concomitant chemoradiotherapy in high-risk gastric cancer.

Quero L, Bouchbika Z, Kouto H, Baruch-Hennequin V, Gornet JM, Munoz N, Cojean-Zelek I, Houdart R, Panis Y, Valleur P, Aparicio T, Maylin C, Hennequin C.

Int J Radiat Oncol Biol Phys. 2012 Jun 1;83(2):574-80. doi: 10.1016/j.ijrobp.2011.07.031. Epub 2011 Nov 16.

PMID:
22099038
20.

Weekly infusional high-dose fluorouracil (HD-FU), HD-FU plus folinic acid (HD-FU/FA), or HD-FU/FA plus biweekly cisplatin in advanced gastric cancer: randomized phase II trial 40953 of the European Organisation for Research and Treatment of Cancer Gastrointestinal Group and the Arbeitsgemeinschaft Internistische Onkologie.

Lutz MP, Wilke H, Wagener DJ, Vanhoefer U, Jeziorski K, Hegewisch-Becker S, Balleisen L, Joossens E, Jansen RL, Debois M, Bethe U, Praet M, Wils J, Van Cutsem E; European Organisation for Research and Treatment of Cancer Gastrointestinal Group; Arbeitsgemeinschaft Internistische Onkologie.

J Clin Oncol. 2007 Jun 20;25(18):2580-5.

PMID:
17577037

Supplemental Content

Support Center